Determinants of Baseline Membrane Lung Resistance in Extracorporeal Membrane Oxygenation
Artificial Organs · 2026-11 · 50 (11) · 1585-1594
DOI: 10.1111/aor.70210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 29.07.2026. Verfasst von Giancarlo Sabetta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Renaissance School of Medicine, Stony Brook University, New York, New York, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Lung. Die Arbeit nennt 24 Literaturangaben. Gefördert von: State University of New York Research Foundation Targeted Research Opportunity.
Abstract (Originalsprache)
Background
Membrane lung (ML) resistance is commonly monitored during extracorporeal membrane oxygenation (ECMO) to forewarn of circuit obstruction, but differences in device design and patient hemorheological factors may complicate interpretation. We sought to determine whether a stable baseline resistance exists shortly after ECMO initiation and to identify factors associated with baseline variability.
Methods
We conducted a single‐center retrospective cohort study of adult patients receiving veno‐arterial or veno‐venous ECMO between 2011 and 2023. Baseline resistance was calculated as the mean inlet–outlet pressure difference normalized to flow during the first 2 and 3 h after initiation. Descriptive statistics and linear regression evaluated associations between patient and device characteristics and baseline resistance.
Results
Among 170 patients, 33 (19.4%) used the Sorin EOS ML and 135 (79.4%) used the Quadrox‐i Small Adult ML, and 2 (1.2%) used other ML models that were excluded from model‐specific analysis. Resistance stabilized within 2–3 h post‐initiation. Baseline resistance varied by ML model: median 31.7 mmHg·min/L for Sorin versus 5.5 mmHg·min/L for Quadrox ( p < 0.0001). Each 1 unit increase in hematocrit increased baseline resistance by 0.54 (95% CI: 0.13 to 0.95) for Sorin, and by 0.05 (95% CI: 0.02 to 0.09) for Quadrox. Female sex was associated with lower resistance compared to male sex (Sorin: −6.92 mmHg·min/L, 95% CI −11.28 to −2.56; Quadrox: −0.63 mmHg·min/L, 95% CI −1.06 to −0.20). Additional associations varied by device model.
Conclusions
Baseline ML resistance reflects device design and patient hemorheology. Early resistance provides a stable baseline reference, though patient hemorheology may confound resistance deviations attributed to true ML obstruction. Device‐specific and physiologically adjusted interpretation may personalize detection of ML obstruction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
- Biostatistical Consulting Core, Office of Scientific Affairs, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
- Department of Family, Population and Preventive Medicine, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
- Department of Anesthesiology, Renaissance School of Medicine, Stony Brook University, New York, New York, USA.
ORCID-Profile: Giancarlo Sabetta, Xiaoyue Zhang, Jonathon Schwartz
Förderung
- State University of New York Research Foundation Targeted Research Opportunity
Zitieren
APA
Sabetta, G., Zhang, X., Yang, J., Zaidi, S., & Schwartz, J. (2026). Determinants of Baseline Membrane Lung Resistance in Extracorporeal Membrane Oxygenation. Artificial Organs, 50(11), 1585-1594. https://doi.org/10.1111/aor.70210
Vancouver
Sabetta G, Zhang X, Yang J, Zaidi S, Schwartz J. Determinants of Baseline Membrane Lung Resistance in Extracorporeal Membrane Oxygenation. Artificial Organs. 2026;50(11):1585-1594. doi:10.1111/aor.70210
BibTeX
@article{Sabetta2026,
author = {Sabetta, Giancarlo and Zhang, Xiaoyue and Yang, Jie and Zaidi, Saleem and Schwartz, Jonathon},
title = {Determinants of Baseline Membrane Lung Resistance in Extracorporeal Membrane Oxygenation},
journal = {Artificial Organs},
year = {2026},
volume = {50},
number = {11},
pages = {1585--1594},
doi = {10.1111/aor.70210}
}
EUVIMED